Business Context and Reporting Period
Company: Axcelis Technologies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: Axcelis is a worldwide producer of ion implantation, dry strip, and other processing equipment for semiconductor fabrication. The company also provides aftermarket services and owns a 50% equity interest in SEN Corporation, a joint venture with Sumitomo Heavy Industries, Ltd., which manufactures and sells ion implantation products in Japan.
Key Financial Metrics
| Metric (in thousands) | Q1 2008 | Q1 2007 |
|---|---|---|
| Total Revenue | $84,894 | $97,526 |
| Gross Profit | $29,216 | $41,250 |
| Gross Margin | 34.4% | 42.3% |
| Operating Loss | $(10,063) | $(1,048) |
| Net Loss | $(11,081) | $2,672 (Income) |
| Net Loss Per Share (Diluted) | $(0.11) | $0.03 |
| Cash and Cash Equivalents | $68,192 | $45,412 (End of Q1 2007) |
| Net Cash Used in Operating Activities | $(12,295) | $(46,720) |
| Convertible Subordinated Debt (Current) | $80,721 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 13% to $84.9 million, driven by a 13.5% drop in product revenue ($69.8M vs. $80.7M) due to a weakening semiconductor market and reduced capital spending. Service revenue declined slightly to $14.0 million.
- Margin Compression: Gross margin fell to 34.4% from 42.3%. Product gross margin dropped to 31.2% due to lower margins on new product revenue (Optima HD) and an unfavorable mix of parts and upgrades.
- Loss of Equity Income: Equity income from the SEN joint venture dropped from $4.7 million in Q1 2007 to negligible amounts in Q1 2008, reflecting lower sales volume in the Japanese market.
- Debt Reclassification: The $75 million principal of Convertible Senior Subordinated Notes (New Notes), due January 2009, was reclassified to current liabilities as of March 31, 2008.
- Restructuring: The company recorded $51,000 in restructuring charges related to a reduction in force initiated in late 2007.
Guidance, Outlook, and Risks
Outlook and Guidance
- Q2 2008 Forecast: Revenue is forecast in the range of $75 million to $90 million. The company expects a loss per share of approximately $0.11 to $0.15.
- Market Conditions: Management expects continued market weakness for the balance of 2008, dependent on semiconductor manufacturers' capital expenditures.
Liquidity and Financing
- Credit Facility: On April 23, 2008, the company entered a revolving credit facility with a $50 million limit (or based on qualifying assets). However, the agreement contains financial covenants limiting net losses in Q2 and Q3 2008 and requiring net income in Q4 2008.
- Covenant Risk: Management forecasts that it will not meet the financial covenant for Q2 2008, though compliance is expected by Q4. Failure to meet covenants could restrict borrowing.
- Cash Position: The company experienced negative operating cash flow in Q1 and anticipates continued outflows in Q2. It is negotiating a sale-leaseback of its headquarters to improve liquidity.
Legal and Contingencies
- Shareholder Litigation: Two class action lawsuits were filed regarding the Board's handling of an unsolicited acquisition offer from Sumitomo Heavy Industries (SHI) at $5.20 per share. The company believes these are without merit.
- Patent Litigation: Varian Semiconductor Associates filed a complaint alleging Axcelis' "Optima products" infringe a Varian patent. Axcelis intends to defend vigorously.
Investor Verification Checklist
- Covenant Compliance: Verify the company's ability to meet the strict financial covenants of the new credit facility in Q2 and Q3 2008 to avoid default.
- Debt Maturity: Confirm refinancing plans for the $75 million Convertible Senior Subordinated Notes maturing in January 2009.
- Optima Product Adoption: Monitor revenue recognition and margin trends for the Optima HD and Optima XE single-wafer tools, which are critical to regaining market share.
- SEN Joint Venture: Track the performance of SEN Corporation, as its equity income and royalty payments are significant but volatile components of Axcelis' results.
- Litigation Status: Monitor developments in the shareholder class actions and the Varian patent infringement suit for potential financial impact.